The submitted manuscript is first reviewed by an editor. It will be evaluated in the office, whether it is suitable for PAd-dawaa: Journal Of Pharmacy  focus and scope or has a major methodological flaw and similarity score by using the iThenticate/ Turnitin/ Plagiarism checker.

The manuscript will be sent to at least two reviewers (double-blind review). Reviewers' comments are then sent to the corresponding author for necessary actions and responses.

The suggested decision will be evaluated in an editorial board meeting. Afterwards, the editor will send the final decision to the corresponding author.

Review Outcomes

Utilizing feedback from the peer review process, the Editor will make a final publication decision. The review process will take approximately maximum of 12 weeks. Decisions categories include:

• Reject - Rejected manuscripts will not be published and authors will not have the opportunity to resubmit a revised version of the manuscript to Ad-dawaa: Journal Of Pharmacy 
• Resubmit for Review– The submission needs to be re-worked, but with significant changes, may be accepted. However, It will require a second round of review.
• Accept with Revisions - Manuscripts receiving an accept-pending-revisions decision will be published in Ad-dawaa: Journal Of Pharmacy  under the condition that minor/major modifications are made. Revisions will be reviewed by an editor to ensure necessary updates are made prior to publication.
• Accept - Accepted manuscripts will be published in the current form with no further modifications required.